Dr Peter Machin

Dr Peter Machin is an independent Drug Discovery Consultant with a medicinal chemistry background. He brings more than thirty years experience of drug discovery and development in major pharmaceutical companies. He has held a number of senior positions; at Roche as Head of Chemistry in the UK, then at SmithKline Beecham as Vice President of Discovery Chemistry Europe and most recently, as Global Senior Vice President of Discovery Research Chemistry at GlaxoSmithKline. He has broad experience of lead discovery and optimization through to development and has been responsible for the identification of a significant number of clinical candidates across a wide range of therapeutic indications including the marketed drugs Saquinavir (HIV proteinase inhibitor) and Retapamulin (antibacterial agent).

Peter Machin holds a first class Honours Degree and PhD in organic chemistry from Imperial College, London. He is a Fellow of the Academy of Medical Sciences and a Fellow of the Royal Society of Chemistry and is also currently the Honorary Treasurer of the Royal Society of Chemistry.